Patents by Inventor John C. Byrd

John C. Byrd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6841565
    Abstract: The invention provides methods for treating a patient with chronic lymphocytic leukemia of B cells (B-CLL). One method comprises administering to a patient with B-CLL, one or more benzamide derivatives, the benzamide derivatives including MS-275 and related compounds. Another method comprises administering to a patient with B-CLL, one or more of the benzamide derivatives, and additionally administering to the patient one or more antibodies immunospecific for 1D10 antigen. Additional methods for inducing apoptosis of B-CLL cells and for increasing expression of 1D10 antigen in B-CLL cells using the benzamide derivatives are also provided.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: January 11, 2005
    Assignee: The Ohio State University
    Inventors: David M. Lucas, Mark R. Parthun, John C. Byrd, Michael R. Grever
  • Patent number: 6316435
    Abstract: Disclosed are methods and kits for treating lymphoproliferative diseases in a host including (co)administering to the host pentostatin, at least one alkylating agent and at least one methylated xanthine.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: November 13, 2001
    Assignee: SuperGen, Inc.
    Inventors: John C. Byrd, Michael R. Grever, Ian W. Flinn, Jamie K. Waselenko
  • Publication number: 20010006974
    Abstract: Disclosed are methods and kits for treating lymphoproliferative diseases in a host including (co)administering to the host pentostatin, at least one alkylating agent and at least one methylated xanthine.
    Type: Application
    Filed: February 24, 1999
    Publication date: July 5, 2001
    Inventors: JOHN C. BYRD, MICHAEL R. GREVER, IAN W. FLINN, JAMIE K. WASELENKO